
    
      The investigators will recruit 150 patients annually for 10 years (adrenal incidentaloma 100
      patients, pheochromocytoma 15 patients, primary aldosteronism 25 patients, adrenal cushing
      syndrome 10 patients, adrenocortical carcinoma 2 patients) and perform hormonal, biochemical,
      imaging exam according to each disease's clinical guidelines. Based on this, the
      investigators will identify pathologic features, complications, and prognostic factors of
      each disease.
    
  